OR WAIT null SECS
October 28, 2025
Article
GLP-1 RA use was linked to a significant survival benefit and reduced risk of iron deficiency anemia in patients with celiac disease.
October 12, 2025
Results from the phase 3 trial show consistent reductions in annualized bleeding rate after 12 months of once-weekly treatment.
October 03, 2025
A study reveals that APOE e4 carriers with atrial fibrillation on Eliquis face increased intracranial hemorrhage risk, highlighting critical genetic implications.
October 01, 2025
Explore key FDA decisions in Q4 2025, impacting treatments for atopic dermatitis, chronic rhinosinusitis, and rare diseases.
September 29, 2025
Denecimig may offer a prophylaxis bleed treatment option for a range of patients across dosing frequencies, age groups, and condition severity.
September 23, 2025
Video
This Sickle Cell Awareness Month, HCPLive draws attention to recent advancements made in SCD treatment and how much still needs to be done to address it.
September 07, 2025
An audio recap of the top 5 stories in healthcare news from the week of 08/31-9/5.
September 06, 2025
Stay updated with the latest healthcare breakthroughs, including FDA news and phase 3 clinical trial data, in this week's essential news roundup.
FDA expands Vonvendi approval for all von Willebrand disease types, enhancing treatment options for adults and children with this rare condition.
September 04, 2025
Agios announces a 3-month extension for mitapivat's FDA review.
